Proton MR Spectroscopy Provides Relevant Prognostic Information in High-Grade Astrocytomas

BACKGROUND AND PURPOSE: There is a large range of survival times in patients with HGA that can only be partially explained by histologic grade and clinical aspects. This study aims to retrospectively assess the predictive value of single-voxel H-1-MRS regarding survival in HGA. MATERIALS AND METHODS...

ver descrição completa

Detalhes bibliográficos
Autores: Majós Torró, Carlos, Bruna, Jordi, Julià Sapé, Margarida, Cos Domingo, Mònica, Camins, Àngels, Gil Gil, Miguel, Acebes Martín, Juan José, Aguilera, Carles, Arús, Carles
Tipo de documento: artigo
Estado:Versão publicada
Data de publicação:2010
País:España
Recursos:Universidad de Barcelona
Repositório:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/222977
Acesso em linha:https://hdl.handle.net/2445/222977
Access Level:Acceso aberto
Palavra-chave:Glioma
Imatges per ressonància magnètica
Gliomas
Magnetic resonance imaging
Descrição
Resumo:BACKGROUND AND PURPOSE: There is a large range of survival times in patients with HGA that can only be partially explained by histologic grade and clinical aspects. This study aims to retrospectively assess the predictive value of single-voxel H-1-MRS regarding survival in HGA. MATERIALS AND METHODS: Pretreatment H-1-MRS in 187 patients with HGA produced 180 spectra at STE (30 ms) and 182 at LTE (136 ms). Patients were dichotomized into 2 groups according to survival better or worse than the median. The spectra of the 2 groups were compared using the Mann-Whitney U test. The points on the spectrum with the most significant differences were selected for discriminating patients with good and poor prognosis. Thresholds were defined with ROC curves, and survival was analyzed by using the Kaplan-Meier method and the Cox proportional hazards model. RESULTS: Four points on the spectrum showed the most significant differences: 0.98 and 3.67 ppm at STE; and 0.98 and 1.25 ppm at LTE (P between <.001 and .011). These points were useful for stratifying 2 prognostic groups (P between <.001 and .003, Kaplan-Meier). The Cox forward stepwise model selected 3 spectroscopic variables: the intensity values of the points 3.67 ppm at STE (hazard ratio, 2.132; 95% Cl, 1.504-3.023), 0.98 ppm at LTE (hazard ratio, 0.499; 95% Cl, 0.339-0.736), and 1.25 ppm at LTE (hazard ratio, 0.574; 95% Cl, 0.368-0.897). CONCLUSIONS: H-1-MRS is of value in predicting the length of survival in patients with HGA and could be used to stratify prognostic groups.